Covid-19 | Subscribe

Archive

Home >  (Page 10)

21 Apr

Posted at 09:41h in

The aim of this newsletter is to disseminate regulatory information on post-marketing surveillance and pharmacovigilance activities rendered by SAHPRA, which includes responsibilities of the SAHPRA Pharmacovigilance unit, reporting tools and pharmacovigilance systems in the country....

01 Feb

Posted at 09:29h in

SAHPRA alerts all healthcare professionals about the risk of serious heart problems, seizures, coma and death associated with the use of high doses of diphenhydramine containing medicines....